National Health (Listed drugs on F1 or F2) Amendment Determination 2016 (No. 4) (PB 37 of 2016) (Cth)

PB 37 of 2016

National Health (Listed drugs on F1 or F2) Amendment Determination 2016 (No. 4)

National Health Act 1953

I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated      29   April 2016

ADRIANA PLATONA

Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health

Part 1         Preliminary

1. Name of Determination

   (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2016 (No. 4).

   (2)   This Determination may also be cited as PB 37 of 2016.

2. Commencement

   This Determination commences on 1 May 2016.

3. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

   Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Beclomethasone

Insert

Bendamustine

[2]     Schedule 1, after item dealing with Eformoterol

Omit

Electrolyte replacement solution

[3]     Schedule 1, after item dealing with Glucose indicator - urine

Omit

Glycerol

[4]     Schedule 1, after item dealing with Nitrofurantoin

Insert

Nivolumab

[5]     Schedule 1, after item dealing with Ticarcillin with clavulanic acid

Omit

Tiludronic acid

[6]     Schedule 2, after item dealing with Alprazolam

Omit

Aluminium hydroxide with magnesium hydroxide

[7]     Schedule 2, after item dealing with Esomeprazole

Insert

Esomeprazole and clarithromycin and amoxycillin

[8]     Schedule 2, after item dealing with Glipizide

Omit

Glucose

[9]     Schedule 2, after item dealing with Simvastatin

Omit

Sodium chloride

Sodium lactate compound